Globestar Therapeutics Corp (GSTC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Total expenses | 42 | 129 | 25 | 79 | 120 |
| Operating Income | -42 | -129 | -25 | -79 | -120 |
| Interest Expense | 4 | 1 | 376 | 104 | 76 |
| Other Income | 6 | -336 | -583 | 0 | 0 |
| Pre-tax Income | -40 | -465 | -984 | -183 | -195 |
| Net Income Continuous | -40 | -465 | -984 | -183 | -195 |
| Net Income | $-40 | $-465 | $-984 | $-183 | $-195 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.02 | 0.00 | -0.01 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.02 | 0.00 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.02 | 0.00 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.02 | 0.00 | -0.01 |
| EBITDA(a) | $-42 | $-129 | $324 | $-10 | $-75 |